Literature DB >> 14625081

Phosphorylation of Gbeta is augmented by chronic morphine and enhances Gbetagamma stimulation of adenylyl cyclase activity.

Sumita Chakrabarti1, Alan R Gintzler.   

Abstract

We previously demonstrated (Chakrabarti, et al., 2001) that in vivo phosphorylation of the Gbeta subunit of G proteins, via protein kinase A (PKA) and protein kinase C (PKC), is dramatically increased following chronic morphine. The present study investigates the PKC isoform selectivity of Gbeta phosphorylation and the consequences thereof on the ability of Gbetagamma to stimulate adenylyl cyclase II (ACII). The catalytic subunit of PKC and PKA, as well as the conventional PKC isoform PKCgamma, was effective in phosphorylating Gbeta. In contrast, Gbeta was only minimally phosphorylated by another conventional isoform, PKCalpha or the atypical isoform PKCzeta. In the presence of activated recombinant Gsalpha, ACII activity was dose dependently stimulated by G(betagamma), the magnitude of which was dependent upon its phosphorylation state. The increment in ACII activity produced by Gbetagamma was increased approximately 2-fold following in vitro phosphorylation by the catalytic subunit of either PKA or PKC. In contrast, the concomitant or sequential phosphorylation of Gbetagamma by PKA and PKC catalytic subunits did not result in an additive enhancement of its ability to stimulate ACII and, in fact, negated the observed enhancing effect of each kinase, individually. Threonine phosphorylated G(beta) occurs naturally in the spinal cord, the levels of which are augmented (approximately 60%) by chronic morphine. The natural occurrence of phosphorylated Gbeta in spinal cord, its up-regulation following chronic morphine and the augmented ability of phosphorylated Gbetagamma to stimulate ACII activity, in the aggregate, indicate that phosphorylation of Gbeta could be a regulatory mechanism causally associated with altered cellular signaling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14625081     DOI: 10.1016/j.molbrainres.2003.09.002

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  11 in total

1.  Pleiotropic opioid regulation of spinal endomorphin 2 release and its adaptations to opioid withdrawal are sexually dimorphic.

Authors:  Sumita Chakrabarti; Nai-Jiang Liu; James E Zadina; Tarak Sharma; Alan R Gintzler
Journal:  J Pharmacol Exp Ther       Date:  2011-10-04       Impact factor: 4.030

2.  Protein kinase C-mediated phosphorylation of the μ-opioid receptor and its effects on receptor signaling.

Authors:  Bo Feng; Zhihua Li; Jia Bei Wang
Journal:  Mol Pharmacol       Date:  2011-01-06       Impact factor: 4.436

3.  Phosphorylation of unique C-terminal sites of the mu-opioid receptor variants 1B2 and 1C1 influences their Gs association following chronic morphine.

Authors:  Sumita Chakrabarti; Nai-Jiang Liu; Alan R Gintzler
Journal:  J Neurochem       Date:  2019-10-20       Impact factor: 5.372

Review 4.  G protein subunit phosphorylation as a regulatory mechanism in heterotrimeric G protein signaling in mammals, yeast, and plants.

Authors:  David Chakravorty; Sarah M Assmann
Journal:  Biochem J       Date:  2018-11-09       Impact factor: 3.857

5.  Diacylglycerol kinase ε deficiency preserves glucose tolerance and modulates lipid metabolism in obese mice.

Authors:  Louise Mannerås-Holm; Milena Schönke; Joseph T Brozinick; Laurène Vetterli; Hai-Hoang Bui; Philip Sanders; Emmani B M Nascimento; Marie Björnholm; Alexander V Chibalin; Juleen R Zierath
Journal:  J Lipid Res       Date:  2017-02-28       Impact factor: 5.922

6.  Chronic opioid treatment augments caveolin-1 scaffolding: relevance to stimulatory μ-opioid receptor adenylyl cyclase signaling.

Authors:  Sumita Chakrabarti; Andrew Chang; Nai-Jiang Liu; Alan R Gintzler
Journal:  J Neurochem       Date:  2016-10-18       Impact factor: 5.372

7.  Down-regulation of c-Cbl by morphine accounts for persistent ERK1/2 signaling in delta-opioid receptor-expressing HEK293 cells.

Authors:  Daniela A Eisinger; Hermann Ammer
Journal:  J Biol Chem       Date:  2009-10-14       Impact factor: 5.157

8.  Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling.

Authors:  Tally M Largent-Milnes; Wenhong Guo; Hoau-Yan Wang; Lindsay H Burns; Todd W Vanderah
Journal:  J Pain       Date:  2008-05-12       Impact factor: 5.820

Review 9.  Relevance of Mu-Opioid Receptor Splice Variants and Plasticity of Their Signaling Sequelae to Opioid Analgesic Tolerance.

Authors:  Sumita Chakrabarti; Nai-Jiang Liu; Alan R Gintzler
Journal:  Cell Mol Neurobiol       Date:  2020-08-17       Impact factor: 5.046

Review 10.  Synthesis of the Mechanisms of Opioid Tolerance: Do We Still Say NO?

Authors:  Laura J Gledhill; Anna-Marie Babey
Journal:  Cell Mol Neurobiol       Date:  2021-03-11       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.